FEMASYS INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.075 USD | -1.38% |
|
-15.75% | +9.74% |
| 20/06 | Femasys Secures CE Mark Approvals for Four Women's Health Products; Shares Up Over 14% | MT |
| 09/05 | Femasys Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart calendar Femasys Inc.
451bee3fbc10ef8057eda.VFdbJeFz-ev9UplQtDGjn-rexier6sFCoKXXi0IgxO4.AAg5a7UsyKCQf_QiwXvH846wsGCan5gq1tHm8QlJtpQOEzBcj0KNj8Q40A~f2b96ec921c434966c0b5c02d01d826b
Upcoming events on Femasys Inc.
Past events on Femasys Inc.
| 09/05/2024 06:00 pm | Q1 2024 Earnings Release |
| 29/03/2024 01:35 am | Q4 2023 Earnings Release |
| 21/03/2024 10:30 pm | Investor Meeting - Fireside Chat |
| 14/11/2023 05:30 pm | Q3 2023 Earnings Release |
| 05/11/2023 | American Association of Gynecologic Laparoscopic Surgeons Meeting |
| 14/10/2023 | American Society of Reproductive Medicine Meeting |
| 11/09/2023 04:30 pm | H.C. Wainwright Global Investment Conference |
| 06/09/2023 07:30 pm | Extraordinary Shareholders Meeting |
| 10/08/2023 05:30 pm | Q2 2023 Earnings Release |
| 22/06/2023 06:30 pm | Maxim Group Virtual Healthcare Conference |
| 21/06/2023 06:30 pm | Annual General Meeting |
| 19/05/2023 | American College of Obstetricians and Gynecologists Clinical & Scientific Meeting |
| 11/05/2023 01:35 am | Q1 2023 Earnings Release |
| 04/05/2023 | American Society for Colposcopy and Cervical Pathology Conference |
| 30/03/2023 05:30 pm | Q4 2022 Earnings Release |
| 11/03/2023 09:30 pm | South By Southwest Conference - Panel |
| 12/12/2022 | American Association for Gynecologic Laparoscopists Meeting |
| 01/12/2022 06:40 pm | Piper Sandler Healthcare Conference |
| 10/11/2022 07:14 pm | Q3 2022 Earnings Release |
| 22/10/2022 | American Society for Reproductive Medicine Scientific Congress |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 1,18 1,25 -5.62% | 1,21 1,35 -10.74% | 1,07 1,18 -8.88% | 4,14 |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -8,34 -8,30 -0.44% | -11,6 -11,7 0.54% | -14,5 -14,3 -1.8% | -13,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | -11,4 -11,5 1.1% | -14,2 -14,1 -1.18% | -14,4 |
|
Net income Million USD | Released Forecast Spread | -6,91 | 0,00 0,00 - | -11,4 -11,5 1.04% | -14,2 -14,1 -1.21% | -14,4 |
|
EPS USD | Released Forecast Spread | -0,80 | -1,12 -0,79 -41.77% | -0,96 -0,98 1.71% | -0,93 -0,95 1.85% | -0,65 |
| Announcement Date | 12/02/21 | 24/03/22 | 30/03/23 | 28/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,32 0,30 7.14% | 0,30 0,31 -3% | 0,35 0,37 -5.75% | 0,23 0,39 -40.55% | 0,29 0,34 -13.54% | 0,32 0,37 -12.35% | 0,24 0,37 -34.78% | 0,21 0,29 -25.68% | 0,27 1,04 -73.81% | 0,76 | 1,19 | 1,87 | 2,31 | 3,03 |
|
EBIT Million USD | Released Forecast Spread | -2,88 -2,50 -15.31% | -2,66 -2,88 7.74% | -3,06 -2,62 -16.64% | -3,00 -3,06 2.06% | -2,94 -3,12 5.87% | -4,08 -3,12 -31% | -4,45 -4,23 -5.14% | -3,46 -4,90 29.33% | -3,12 | -3,76 | -3,69 | |||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -2,63 -2,77 4.77% | -2,98 -2,54 -17.34% | -2,89 -3,01 4.17% | -2,89 -3,07 5.72% | -4,00 -3,12 -28.29% | -4,41 -4,17 -5.78% | -3,60 -4,80 25.01% | -3,19 | -3,83 | -3,75 | ||||
|
Net income Million USD | Released Forecast Spread | -2,63 -2,77 4.77% | -2,98 -2,54 -17.34% | -2,89 -3,01 3.96% | -2,89 -3,07 5.72% | -4,00 -3,12 -28.29% | -4,41 -4,17 -5.88% | -3,60 -4,80 25.01% | -3,19 | -3,83 | -3,75 | ||||
|
EPS USD | Released Forecast Spread | -0,22 -0,23 4.35% | -0,25 -0,24 -6.38% | -0,24 -0,26 6.49% | -0,25 -0,26 3.85% | -0,22 -0,20 -10% | -0,26 -0,22 -16.42% | -0,19 -0,21 10.59% | -0,17 -0,21 17.07% | -0,16 | -0,17 | -0,16 | -0,18 | -0,14 | |
| Announcement Date | 11/05/22 | 10/08/22 | 10/11/22 | 30/03/23 | 11/05/23 | 10/08/23 | 14/11/23 | 28/03/24 | 09/05/24 | - | - | - | - | - |
| 27/06/2024 | SCHOTT PHARMA AG & CO. KGAA: Q2 2024 Earnings Release |
| 05/07/2024 | MANI, INC.: Q3 2024 Earnings Release |
| 11/07/2024 10:30 am | GERRESHEIMER AG: Q2 2024 Earnings Release |
| 12/07/2024 10:30 am | ARJO AB: Q2 2024 Earnings Release |
| 12/07/2024 11:00 am | XVIVO PERFUSION AB: Q2 2024 Earnings Release |
| 18/07/2024 | ABBOTT LABORATORIES: Q2 2024 Earnings Release (Projected) |
| 18/07/2024 | MEDMIX AG: Q2 2024 Earnings Release |
| 19/07/2024 10:30 am | SARTORIUS STEDIM BIOTECH: Q2 2024 Earnings Release |
| 23/07/2024 | NEOGEN CORPORATION: Q4 2024 Earnings Release (Projected) |
| 24/07/2024 | CONMED CORPORATION: Q2 2024 Earnings Release (Projected) |
Past sector events for Femasys Inc.
| 18/06/2024 04:30 pm | PATTERSON COMPANIES, INC.: Q4 2024 Earnings Release |
| 07/06/2024 12:44 pm | TAIDOC TECHNOLOGY CORPORATION: May 2024 Sales and Revenue Release |
| 05/06/2024 03:30 pm | MESA LABORATORIES, INC.: Q4 2024 Earnings Release |
| 28/05/2024 02:00 am | FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED: Q4 2024 Earnings Release |
| 23/05/2024 04:15 pm | MEDTRONIC PLC: Q4 2024 Earnings Release |
| 22/05/2024 10:30 am | YPSOMED HOLDING AG: Q4 2024 Earnings Release |
| 17/05/2024 01:49 pm | POLY MEDICURE LIMITED: Q4 2024 Earnings Release |
| 16/05/2024 11:30 am | CONVATEC GROUP PLC: Q1 2024 Sales and Revenue Release - Trading Update |
| 15/05/2024 07:30 am | HOYA CORPORATION: Q4 2023 Earnings Release |
| 14/05/2024 10:30 am | AMBU A/S: Q2 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- FEMY Stock
- Calendar Femasys Inc.
